SILVERARC CAPITAL MANAGEMENT, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$0
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 32.54K shares | 6.51M | $200.16 | 32.54K |
Q3 2022 | call | Decrease | -100.00% | -40K shares | -5.83M | $200.16 | 0 |
Q2 2022 | call | Increase | 0.00% | 40K shares | 5.83M | $145.85 | 40K |